Oxytocin and Resting State fMRI

NCT02689596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-02-24

No results posted yet for this study

Summary

The goal of the study is to investigate the effects of intranasal oxytocin (OT) or placebo to resting state brain activity in healthy males.

Conditions

  • Healthy

Interventions

DRUG

Oxytocin

OTHER

Placebo

Sponsors & Collaborators

  • University Hospital Heidelberg

    lead OTHER

Study Design

Purpose
BASIC_SCIENCE

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689596 on ClinicalTrials.gov